MedPath

Treatment of Children cases of white patches (Safed dag) by application Ayurvedic drug and Ayurvedeeya procedures of body cleaning.

Phase 2
Not yet recruiting
Conditions
Shwitra or Vitiigo (Leucoderma)
Registration Number
CTRI/2018/05/013844
Lead Sponsor
Dr Shrinidhi Kumar k
Brief Summary

Vitiligo or leucoderma is one such clinicaldermatological condition which has been analogues with *Shwitra* in Ayurvedic literature which is responsible for majorcosmetic concern in population. Although *Shwitra*don’t produces pain, ulcer or discomfort, but eventually creates an inferioritycomplex in individuals, ending up in disturbed social, personnel, psychologicaland educational life and considered as social stigma.

The present study has been planned to provide an effective, costeffective, easy treatment for vitiligo by using Ayurvedic principle as humanpopulation especially children is suffering from *Shwitra* on a large scale and incidences are rising day by day.

Presentstudy has been designed to study the role of *Sanshodhana Karma* followed by *PooteekadiLepa*, externally, over the discolored patches in children with subsequentexposure to sunlight. *Pooteekadi Lepa* has been quoted in the classics for managementof *Shwitra* and same on been selectedin the present study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients of either sex between age group of 05-15 years.
  • Children diagnosed as leucoderma or Vitiligo as per contemporary medical sciences or Shwitra as per clinical features mentioned in Ayurvedic texts.
Exclusion Criteria
  • Children below 05 and above 15 years of age.
  • Children with Albinism will be excluded.
  • White anesthetic spots, which are characteristic of leprosy.
  • Old refractory cases not responding after extensive use of modern medicine.
  • Patches in genital area, lip area are excluded from the study.
  • Vitiligo patches complicated by eczema.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change at the site of lesion with formation of the blebs with subsequent reddish discolorization.3 months
Secondary Outcome Measures
NameTimeMethod
Complete healthy blackish Pigmentation of the whitish patch3 months

Trial Locations

Locations (1)

NATIONAL INSTITUTE OF AYURVEDA,JAIPUR

🇮🇳

Jaipur, RAJASTHAN, India

NATIONAL INSTITUTE OF AYURVEDA,JAIPUR
🇮🇳Jaipur, RAJASTHAN, India
Dr Shrinidhi kumar K
Principal investigator
7877151575
ashanidhiacharya@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.